Benoit Gourdier's most recent trade in Avantor Inc. was a trade of 3,029 Common Stock done at an average price of $8.9 . Disclosure was reported to the exchange on Feb. 23, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Avantor Inc | Benoit Gourdier | EVP, Bioscience & Medtech | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.89 per share. | 23 Feb 2026 | 3,029 | 362,859 (0%) | 0% | 8.9 | 26,928 | Common Stock |
| Avantor Inc | Benoit Gourdier | EVP, Bioscience & Medtech | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2026 | 528,848 | 528,848 | - | - | Stock Options (Right to Buy) | |
| Avantor Inc | Benoit Gourdier | EVP, Bioscience & Medtech | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2026 | 134,364 | 370,048 (0%) | 0% | 0 | Common Stock | |
| Avantor Inc | Benoit Gourdier | EVP, Bioscience & Medtech | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.03 per share. | 19 Feb 2026 | 4,160 | 365,888 (0%) | 0% | 9.0 | 37,565 | Common Stock |
| Avantor Inc | Benoit Gourdier | EVP, Bioscience Production | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.77 per share. | 02 Oct 2025 | 1,264 | 235,684 (0%) | 0% | 13.8 | 17,405 | Common Stock |
| Avantor Inc | Benoit Gourdier | EVP, Bioscience Production | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 162,866 | 236,948 (0%) | 0% | 0 | Common Stock | |
| Avantor Inc | Benoit Gourdier | EVP, Bioscience Production | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 86,565 | 86,565 | - | - | Stock Options (Right to Buy) | |
| Avantor Inc | Benoit Gourdier | EVP, Bioscience Production | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 35,734 | 76,924 (0%) | 0% | 0 | Common Stock | |
| Avantor Inc | Benoit Gourdier | EVP, Bioscience Production | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.30 per share. | 20 Feb 2025 | 2,842 | 74,082 (0%) | 0% | 17.3 | 49,167 | Common Stock |
| Avantor Inc | Benoit Gourdier | EVP, Bioscience Production | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.54 per share. | 02 Oct 2024 | 1,263 | 41,190 (0%) | 0% | 25.5 | 32,257 | Common Stock |
| Avantor Inc | Benoit Gourdier | EVP, Biopharma Production | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 62,753 | 62,753 | - | - | Stock Options (Right to Buy) | |
| Avantor Inc | Benoit Gourdier | EVP, Biopharma Production | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 25,667 | 42,453 (0%) | 0% | 0 | Common Stock | |
| Avantor Inc | Benoit Gourdier | EVP, Biopharma Production | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2023 | 39,281 | 39,281 | - | - | Stock Options (Right to Buy) | |
| Avantor Inc | Benoit Gourdier | EVP, Biopharma Production | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2023 | 16,786 | 16,786 (0%) | 0% | 0 | Common Stock |